Literature DB >> 7950666

Peripheral neuropathy with bezafibrate.

C J Ellis1, W E Wallis, M Caruana.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7950666      PMCID： PMC2541140          DOI： 10.1136/bmj.309.6959.929b

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  2 in total

1.  Clofibrate-induced myopathy and neuropathy.

Authors:  R Gabriel; J M Pearce
Journal:  Lancet       Date:  1976-10-23       Impact factor: 79.321

Review 2.  Bezafibrate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hyperlipidaemia.

Authors:  J P Monk; P A Todd
Journal:  Drugs       Date:  1987-06       Impact factor: 9.546
  2 in total
  2 in total

Review 1.  Bezafibrate. An update of its pharmacology and use in the management of dyslipidaemia.

Authors:  K L Goa; L B Barradell; G L Plosker
Journal:  Drugs       Date:  1996-11       Impact factor: 9.546

2.  Lipid lowering drugs prescription and the risk of peripheral neuropathy: an exploratory case-control study using automated databases.

Authors:  Giovanni Corrao; Antonella Zambon; Lorenza Bertù; Edoardo Botteri; Olivia Leoni; Paolo Contiero
Journal:  J Epidemiol Community Health       Date:  2004-12       Impact factor: 3.710
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.